ask="46.60"
ask_size="100"
average_daily_volume="1129490"
bid="42.62"
bid_size="1000"
book_value="3.62"
change="-0.59"
change_from_200_day_moving_average="-1.62"
change_from_50_day_moving_average="1.84"
change_from_52_week_high="-10.97"
change_From_52_week_low="12.00"
change_in_percent="-1.32%"
close="44.18"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.63"
ebitda="-145.92M"
eps_estimate_current_year="-2.34"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-1.30"
ex_dividend_date="N/A"
float_shares="85906000"
high="45.76"
high_52_weeks="55.15"
last_trade_date="3/2/2017"
last_trade_price="44.18"
last_trade_size="42683"
last_trade_time="4:00pm"
low="43.77"
low_52_weeks="32.18"
market_capitalization="3.85B"
moving_average_200_day="45.80"
moving_average_50_day="42.34"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="67.67"
open="44.78"
pe_ratio="N/A"
peg_ratio="0.51"
percent_change_from_200_day_moving_average="-3.53%"
percent_change_from_50_day_moving_average="+4.34%"
percent_change_from_52_week_high="-19.89%"
percent_change_from_52_week_low="+37.29%"
previous_close="44.77"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="12.35"
price_per_sales="260.01"
revenue="15.00M"
shares_outstanding="87114000"
short_ratio="3.01"
stock_exchange="NMS"
symbol="NBIX"
volume="968453"
weeks_range_52="32.18 - 55.15"
